Press "esc" to clear
Go to Advanced Search

Showing results

110 of 1880
Embargo will expire:
20-Aug-2018 3:00 PM EDT
Released to reporters:
17-Aug-2018 11:30 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 20-Aug-2018 3:00 PM EDT

Article ID: 699063

First Mouse Model to Mimic Lung Disease Could Speed Discovery of More Effective Treatments

Perelman School of Medicine at the University of Pennsylvania

A team of researchers from Penn Medicine has developed the first mouse model with an IPF-associated mutation, which induces scarring and other damage similar to what is observed in humans suffering from the condition.

Released:
15-Aug-2018 4:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Comment
CarlJuneJMECheadshot.jpg

Article ID: 698998

Penn Medicine’s Carl June Receives 2018 Albany Prize

Perelman School of Medicine at the University of Pennsylvania

Carl June, MD, a gene therapy pioneer at the Abramson Cancer Center of the University of Pennsylvania, will receive the 2018 Albany Medical Center Prize in Medicine and Biomedical Research.

Released:
15-Aug-2018 8:50 AM EDT
EXPERT AVAILABLE
Open in New Tab
Comment

Article ID: 698982

Seven Ways You Are Hurting Your Sleep This Summer

Perelman School of Medicine at the University of Pennsylvania

Summer is the season of barbeque, beach trips, and some of the simplest joys of life, but if you’re not careful, it can also be the lone enemy of one of the most important joys of them all: sleep.

Released:
14-Aug-2018 2:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Comment

Article ID: 698940

Alarming” Diabetes Epidemic in Guatemala Tied to Aging, Not Obesity

Perelman School of Medicine at the University of Pennsylvania

The diabetes epidemic in Guatemala is worse than previously thought: more than 25 percent of its indigenous people, who make up 60 percent of the population, suffer from type 2 diabetes or pre-diabetes, suggests a new study published in PLOS One from researchers at the Penn Center for Global Health.

Released:
14-Aug-2018 8:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Comment
ShorterBoniniMolCellimageAug2018.jpg
  • Embargo expired:
    9-Aug-2018 11:00 AM EDT

Article ID: 698745

Drugs in Development for Cancer May Also Fight Brain Diseases, including ALS

Perelman School of Medicine at the University of Pennsylvania

A class of cancer drugs called PARP inhibitors could be useful for treating and preventing brain disorders, including ALS (Lou Gehrig’s disease) and some forms of frontotemporal degeneration, by halting the misplacement of specific proteins that affect nerve cells.

Released:
8-Aug-2018 5:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Comment

Article ID: 698714

Penn Medicine’s Commitment to Encouraging Healthy Lifestyles for Patients and Staff Now Extends to Food and Beverages

Perelman School of Medicine at the University of Pennsylvania

Sodas, sports drinks, sweetened juices, fast food and grab-and-go vending machine snacks are staples of many American diets, and this fare has become a major contributor to obesity and chronic disease across the nation. In fact, according to the Centers for Disease Control and Prevention, the added sugars from sugary drinks are directly tied to an increased risk of obesity and type 2 diabetes. Penn Medicine is taking strides to eliminate these foods from its facilities in an effort to ensure that the food its serves aligns with its missions to care for, educate and empower patients who are coping with heart disease, diabetes, and many other illnesses.

Released:
9-Aug-2018 9:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Comment

Article ID: 698744

Inaugural Class of the Michael Brown Penn-GSK Postdoctoral Fellowship Award Program Commence Unique Collaborative Training

Perelman School of Medicine at the University of Pennsylvania

Four Penn Medicine postdoctoral trainees have been awarded three-year fellowships through a newly established program, the Michael Brown Penn-GSK Postdoctoral Fellowship Award Program from the Perelman School of Medicine at the University of Pennsylvania, in partnership with GlaxoSmithKline.

Released:
8-Aug-2018 5:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Comment

Article ID: 698743

Penn Biomedical Graduate Studies Program Receives $2 Million Gift from the Blavatnik Family Foundation to Support Scientists in Training

Perelman School of Medicine at the University of Pennsylvania

The Perelman School of Medicine at the University of Pennsylvania has received a $2 million gift from the Blavatnik Family Foundation to establish the Blavatnik Family Fellowship in Biomedical Research in the Penn Biomedical Graduate Studies (BGS) program.

Released:
8-Aug-2018 5:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Comment
GuoXuNatureimageAug2018.png
  • Embargo expired:
    8-Aug-2018 1:00 PM EDT

Article ID: 698611

Cancer Cells Send Out “Drones” to Battle Immune System from Afar

Perelman School of Medicine at the University of Pennsylvania

Checkpoint inhibitor therapies have made metastatic melanoma and other cancers a survivable condition for 20 to 30 percent of treated patients, but clinicians have had very limited ways of knowing which patients will respond. Researchers have uncovered a novel mechanism by which tumors suppress the immune system. Their findings also usher in the possibility that a straightforward blood test could predict and monitor cancer patients’ response to immunotherapy.

Released:
6-Aug-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Comment

Showing results

110 of 1880





Chat now!